* above transactions were completed by Ceros Capital Markets or by Chris Dewey prior to joining Ceros Capital Markets.view portfolio
Ceros Capital Markets is a global investing platform for companies in the medical device, robotics, and digital health space. We bring institutional quality deals to sophisticated investors who understand the synergies between innovation and healthcare.
Our deals have been sourced and vetted by the Ceros team and our strategic advisors, who are among the most successful serial entrepreneurs in MedTech. These deals provide investors with the opportunity to join us in pushing the boundaries of robotics, disrupting the medical industry, and fueling innovation to help change lives.
Learn MoreMomentis Annovo®
May 18, 2021Momentis is a medical device company that develops robotic surgical solutions that features miniature humanoid-shaped robotic arms. Ceros Capital Markets acted as a placement agent for +$40M in Momenti's Series D financing. Read More
(TIME) DermaSensor’s titular device is the first of its kind cleared by the FDA for use by non-specialist physicians. It uses optical spectroscopy—the deployment of light to analyze tissues—to promptly detect likely cancerous skin lesions at a rate similar to that of in-person dermatologists.
Read More(Podcast) With over four decades of experience in commodities and securities, Mark shares his remarkable journey from Zimbabwe to the helm of a thriving financial services company. We delve into the dynamic world of capital markets, exploring how Ceros is making an impact in med tech and biotech.
Read MoreIf you’re interested in investing on the Ceros Capital Markets platform or pitching your company, please fill out the request form below with the appropriate selection.